Avidity Biosciences, Inc. (RNA) has seen some recent volatility in the stock market and its common shares closed trading at $24.73 yesterday. Traders are starting to take notice of RNA as the common shares traded as high as $26.40 and as low as $24.49 in the last market trading session.
Avidity Biosciences, Inc. (RNA) average trading volume is 202.55K. However, in the last market trading session Avidity Biosciences, Inc. (RNA) exchanged 147,945 shares. The First downside support level on RNA is $23.16 and the First resistance level on RNA is $35.94. RNA 50day moving average is $29.44 and RNA 200-day moving average is $28.68.
Avidity Biosciences, Inc. (RNA) most current performance has been specified by the recent movement in RNA common shares. RNA has performed -13.26% over the past 4 weeks, RNA has performed -11.58% over the past 90 days and RNA has shown – over the past 1 year. Avidity Biosciences, Inc. (RNA) has a 12 month range of $23.06 to $37.46. Avidity Biosciences, Inc. (RNA) is trading 7.24% from its 12 month low and -33.98% from its 12 month high. Avidity Biosciences, Inc. (RNA) is indicating a 4.76% short float indicating the quantity short in the float.
RNA has 37.53M shares outstanding and 30.07M shares in the float. Avidity Biosciences, Inc. (RNA) at this time has a market cap of $985.00M and income of -33.70M. The EPS next quarter for RNA is -0.37 and projected EPS next year is 11.90%. The market cap of Avidity Biosciences, Inc. (RNA) at $985.00M represents how many Traders own shares of RNA and is based off the last price ($24.73) of RNA and the quantity of shares outstanding (37.53M) with Avidity Biosciences, Inc. (RNA).
Avidity Biosciences, Inc. (RNA) has total cash (mrq) of 352.45M, total cash per share (mrq) of 9.39, total debt of RNA remains at 679k and total debt/equity (mrq) is 0.20. . Avidity Biosciences, Inc. (RNA) operating cash flow (ttm) is -25.84M.
RNA is trading -11.99% below (bearish) its SMA20, -16.74% below (bearish) its SMA50 and -13.90% below (bearish) its SMA200.